Systemic analgesia and co-analgesia

Acta Anaesthesiologica Belgica

Volumn 57, Issue 2, 2006, Pages 113-120

  Vandermeulen, E ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

17 METHYLNALTREXONE; ALVIMOPAN; CELECOXIB; CLONIDINE; CORTICOSTEROID; DEXAMETHASONE; DEXMEDETOMIDINE; GABAPENTIN; IBUPROFEN; KETAMINE; KETOROLAC; LIDOCAINE; METHYLPREDNISOLONE; MEXILETINE; MORPHINE; NALTREXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OPIATE ANTAGONIST; PARACETAMOL; PARECOXIB; PLACEBO; PREGABALIN; ROFECOXIB;

ANALGESIC ACTIVITY; CHRONIC PAIN; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERANCE; EPIDURAL ANESTHESIA; HUMAN; HYPERALGESIA; ILEUS; INTESTINAL DYSMOTILITY; LOCAL ANESTHESIA; NAUSEA; PATIENT CONTROLLED ANALGESIA; PERIOPERATIVE PERIOD; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PREVALENCE; PRURITUS; RESPIRATION DEPRESSION; REVIEW; SEDATION; SINGLE DRUG DOSE; URINE RETENTION; VOMITING;

AMINES; ANALGESICS; ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; CYCLOHEXANECARBOXYLIC ACIDS; DEXMEDETOMIDINE; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; KETAMINE; LIDOCAINE; NARCOTIC ANTAGONISTS; PAIN, POSTOPERATIVE;

EID: 33745949730     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Arain S. R., Ruehlow R. M., Uhrich T. D., Ebert T. J., The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery, ANESTH. ANALG., 98, 153-158, table of contents, 2004.
2. Ballantyne J. C., Carr D. B., deFerranti S., et al., The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials, ANESTHESIA & ANALGESIA, 86, 598-612, 1998.
3. Becke K., Albrecht S., Schmitz B., et al., Intraoperative low-dose S-ketamine has no preventive effects on postoperative pain and morphine consumption after major urological surgery in children, PAEDIATR. ANAESTH., 15, 484-490, 2005.
4. Bernard J. M., Quintin L., Pinaud M., [Clonidine: from the treatment of hypertension to its use in anesthesia. I. Main effects and mechanism of action of clonidine], ANN. FR. ANESTH. RÉANIM., 9, 59-66, 1990.
5. Bernard J. M., Quintin L., Pinaud M., [Clonidine: from the treatment of hypertension to its use in anesthesia. II: Perioperative use], ANN. FR. ANESTH. REANIM., 9, 423-432, 1990.
6. Bisgaard T., Klarskov B., Kehlet H., Rosenberg J., Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial, ANN. SURG., 238, 651-660, 2003.
7. Chaplan S. R., Bach F. W., Yaksh T. L., Systemic use of local anesthetics in pain states. In: Yaksh T. L., Lynch C., Zapol W. M., Maze M., Biebuyck J. F., Saidman L. J., eds. Anesthesia: Biologic Foundations. Philadelphia: Lippincott-Raven, 977-986, 1997.
8. Cornet P., Kaba A., Detroz B., et al., Benefits of intravenous lidocaine infusion in an acute rehabilitation program after laparoscopic colectomy, EUR. J. ANAESTHESIOL., 21 (Suppl. 32), A764, 2004.
9. Dahl J. B., Mathiesen O., Moiniche S., 'Protective premedication': an option with gabapentin and related drugs? A review of gabapentin and pregabalin in in the treatment of post-operative pain, ACTA ANAESTHESIOL. SCAND., 48, 1130-1136, 2004.
10. Delaney C. P., Weese J. L., Hyman N. H., et al., Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery, Dis. COLON RECTUM, 48, 1114-1125; discussion 1125-1116; author reply 1127-1119, 2005.
11. Dirks J., Fabricius P., Petersen K. L., et al., The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers, ANESTH. ANALG., 91, 967-972, 2000.
12. Dirks J., Fredensborg B. B., Christensen D., et al., A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy, ANESTHESIOLOGY, 97, 560-564, 2002.
13. Dix P., Martindale S., Stoddart P. A., Double-blind randomized placebo-controlled trial of the effect of ketamine on postoperative morphine consumption in children following appendicectomy, PAEDIATR. ANAESTH., 13, 422-426, 2003.
14. Ebert T. J., Hall J. E., Barney J. A., et al., The effects of increasing plasma concentrations of dexmedetomidine in humans, ANESTHESIOLOGY, 93, 382-394, 2000.
15. Eisenach J. C., De Kock M., Klimscha W., alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995), ANESTHESIOLOGY, 85, 655-674, 1996.
16. Elia N., Tramer M. R., Ketamine and postoperative pain-a quantitative systematic review of randomised trials, PAIN, 113, 61-70, 2005.
17. Fassoulaki A., Patris K., Sarantopoulos C., Hogan Q., The analgesic effect of gabapentin and mexiletine after breast surgery for cancer, ANESTH. ANALG., 95, 985-991, table of contents, 2002.
18. Ferreira S. H., Cunha F. Q., Lorenzetti B. B., et al., Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone, BR. J. PHARMACOL., 121, 883-888, 1997.
19. Field M. J., Holloman E. F., McCleary S., et al., Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain, J. PHARMACOL. EXP. THER., 282, 1242-1246, 1997.
20. Finnerup N. B., Biering-Sorensen F., Johannesen I. L., et al., Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial, ANESTHESIOLOGY, 102, 1023-1030, 2005.
21. Ghilardi J. R., Svensson C. I., Rogers S. D., et al., Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia, J. NEUROSCI., 24, 2727-2732, 2004.
22. Gilron I., Corticosteroids in postoperative pain management: future research directions for a multifaceted therapy, ACTA ANAESTHESIOL. SCAND., 48, 1221-1222, 2004.
23. Gilron I., Biederman J., Jhamandas K., Hong M., Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests, ANESTHESIOLOGY, 98, 1288-1292, 2003.
24. Gilron I., Orr E., Tu D., et al., A placebo-controlled randomized clinical trial of perioperative administration of gabapentin, rofecoxib and their combination for spontaneous and movement-evoked pain after abdominal hysterectomy, PAIN, 113, 191-200, 2005.
25. Groudine S. B., Fisher H. A., Kaufman R. P., Jr., et al., Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy, ANESTH. ANALG., 86, 235-239, 1998.
26. Hall J. E., Uhrich T. D., Barney J. A., et al., Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions, ANESTH. ANALG., 90, 699-705, 2000.
27. Henzi I., Walder B., Tramer M. R., Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review, ANESTH. ANALG., 90, 186-194, 2000.
28. Hill C. M., Balkenohl M., Thomas D. W., et al., Pregabalin in patients with postoperative dental pain, EUR. J. PAIN, 5, 119-124, 2001.
29. Hollmann M. W., Difazio C. A., Durieux M. E., Ca-signaling G-protein-coupled receptors: a new site of local anesthetic action?, REG. ANESTH. PAIN MED., 26, 565-571, 2001.
30. Hollmann M. W., Durieux M. E., Local anesthetics and the inflammatory response: a new therapeutic indication?, ANESTHESIOLOGY, 93, 858-875, 2000.
31. Hollmann M. W., Strumper D., Durieux M. E., The poor man's epidural: systemic local anesthetics for improving postoperative outcomes, MED. HYPOTHESES, 63, 386-389, 2004.
32. Hollmann M. W., Strumper D., Herroeder S., Durieux M. E., Receptors, G proteins, and their interactions, ANESTHESIOLOGY, 103, 1066-1078, 2005.
33. Hollmann M. W., Wieczorek K. S., Berger A., Durieux M. E., Local anesthetic inhibition of G protein-coupled receptor signaling by interference with Galpha(q) protein function, MOL. PHARMACOL., 59, 294-301, 2001.
34. Holte K., Kehlet H., Postoperative ileus: a preventable event, BR. J. SURG., 87, 1480-1493, 2000.
35. Huang G. S., Chang J. H., Lee M. S., et al., The effect of anesthetic techniques on hemostatic function in arthroscopic surgery: evaluation by thromboelastography, ACTA ANAESTHESIOL. SIN., 40, 121-126, 2002.
36. Kaba A., Detroz B. J., Laurent S. R., et al., Acute rehabilitation program after laparoscopic colectomy using intravenous lidocaine, ACTA CHIR. BELG., 105, 53-58, 2005.
37. Karst M., Kegel T., Lukas A., et al., Effect of celecoxib and dexamethasone on postoperative pain after lumbar disc surgery, NEUROSURGERY, 53, 331-336; discussion 336-337, 2003.
38. Kawamata M., Takahashi T., Kozuka Y., et al., Experimental incision-induced pain in human skin: effects of systemic lidocaine on flare formation and hyperalgesia, PAIN, 100, 77-89, 2002.
39. Kehlet H., Holte K., Effect of postoperative analgesia on surgical outcome, BRITISH JOURNAL OF ANAESTHESIA, 87, 62-72, 2001.
40. Kehlet H., Werner M., Perkins F., Balanced analgesia: what is it and what are its advantages in postoperative pain?, DRUGS, 58, 793-797, 1999.
41. Koppert W., [Opioid-induced analgesia and hyperalgesia], SCHMERZ, 19, 386-390, 392-384, 2005.
42. Koppert W., Dern S. K., Sittl R., et al., A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine, ANESTHESIOLOGY, 95, 395-402, 2001.
43. Koppert W., Ostermeier N., Sittl R., et al., Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action, PAIN, 85, 217-224, 2000.
44. Koppert W., Weigand M., Neumann F., et al., Perioperative intravenous lidocaine has preventive effects on post-operative pain and morphine consumption after major abdominal surgery, ANESTH. ANALG., 98, 1050-1055, table of contents, 2004.
45. Koppert W., Zeck S., Sittl R., et al., Low-dose lidocaine suppresses experimentally induced hyperalgesia in humans, ANESTHESIOLOGY, 89, 1345-1353, 1998.
46. Kurz A., Sessler D. I., Opioid-induced bowel dysfunction: pathophysiology and potential new therapies, DRUGS, 63, 649-671, 2003.
47. Liu S. S., Hodgson P. S., Carpenter R. L., Fricke J. R., Jr., ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia, CLIN. PHARMACOL. THER., 69, 66-71, 2001.
48. Luckey A., Livingston E., Tache Y., Mechanisms and treatment of postoperative ileus, ARCH. SURG., 138, 206-214, 2003.
49. Luo Z. D., Chaplan S. R., Higuera E. S., et al., Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats, J. NEUROSCI., 21, 1868-1875, 2001.
50. Mao J., Price D. L., Mayer D. J., Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions, PAIN, 62, 259-274, 1995.
51. Menigaux C., Adam F., Guignard B., et al., Preoperative gabapentin decreases anxiety and improves early functional recovery from knee surgery, ANESTH. ANALG., 100, 1394-1399, table of contents, 2005.
52. Nagy I., Woolf C. J., Lignocaine selectively reduces C fibre-evoked neuronal activity in rat spinal cord in vitro by decreasing N-methyl-D-aspartate and neurokinin receptor-mediated post-synaptic depolarizations; implications for the development of novel centrally acting analgesics, PAIN, 64, 59-70, 1996.
53. Ness T. J., Intravenous lidocaine inhibits visceral nociceptive reflexes and spinal neurons in the rat, ANESTHESIOLOGY, 92, 1685-1691, 2000.
54. Pandey C. K., Priye S., Singh S., et al., Preemptive use of gabapentin significantly decreases postoperative pain and rescue analgesic requirements in laparoscopic cholecystectomy, CAN. J. ANAESTH., 51, 358-363, 2004.
55. Pandey C. K., Singhal V., Kumar M., et al., Gabapentin provides effective postoperative analgesia whether administered pre-emptively or post-incision, CAN. J. ANAESTH., 52, 827-831, 2005.
56. Paulson D. M., Kennedy D. T., Donovick R. A., et al., Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction-a 21-day treatment-randomized clinical trial, J. PAIN, 6, 184-192, 2005.
57. Puig S., Sorkin L. S., Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity, PAIN, 64, 345-355, 1996.
58. Richebe P., Rivat C., Cretan C., et al., Nitrous oxide revisited: evidence for potent antihyperalgesic properties, ANESTHESIOLOGY, 103, 845-854, 2005.
59. Richebe P., Rival C., Laulin J. P., et al., Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats, ANESTHESIOLOGY, 102, 421-428, 2005.
60. Rodgers A., Walker N., Schug S., et al., Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials, BMJ, 321, 1493-1497, 2000.
61. Romsing J., Moiniche S., Mathiesen O., Dahl J. B., Reduction of opioid-related adverse events using opioid-sparing analgesia with COX-2 inhibitors lacks documentation: a systematic review, ACTA ANAESTHESIOL. SCAND., 49, 133-142, 2005.
62. Romundstad L., Breivik H., Niemi G., et al., Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects, ACTA ANAESTHESIOL. SCAND., 48, 1223-1231, 2004.
63. Romundstad L., Breivik H., Roald H., et al., Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: a single-dose, randomized, parallel-group study with methylprednisolone 125 mg, parecoxib 40 mg, and placebo, ANESTH. ANALG., 102, 418-425, 2006.
64. Russell J., Bass P., Goldberg L. I., et al., Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists, EUR. J. PHARMACOL., 78, 255-261, 1982.
65. Sauerland S., Nagelschmidt M., Mallmann P., Neugebauer E. A., Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review, DRUG SAF., 23, 449-461, 2000.
66. Schleimer R. P., An overview of glucocorticoid anti-inflammatory actions, EUR. J. CLIN. PHARMACOL., 45 Suppl 1, S3-7; discussion S43-44, 1993.
67. Schmid R. L., Sandler A. N., Katz J., Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes, PAIN, 82, 111-125, 1999.
68. Schmier J. K., Palmer C. S., Flood E. M., Gourlay G., Utility assessments of opioid treatment for chronic pain, PAIN MED., 3, 218-230, 2002.
69. Shelly M. P., Dexmedetomidine: a real innovation or more of the same?, BR. J. ANAESTH., 87, 677-678, 2001.
70. Simonnet G., Opioids: from analgesia to anti-hyperalgesia?, PAIN, 118, 8-9, 2005.
71. Smith W. C., Bourne D., Squair J., et al., A retrospective cohort study of post mastectomy pain syndrome, PAIN, 83, 91-95, 1999.
72. Sotgiu M. L., Lacerenza M., Marchettini P., Effect of systemic lidocaine on dorsal horn neuron hyperactivity following chronic peripheral nerve injury in rats, SOMATOSENS. MOT. RES., 9, 227-233, 1992.
73. Spaulding T. C., Fielding S., Venafro J. J., Lal H., Antinociceptive activity of clonidine and its potentiation of morphine analgesia, EUR. J. PHARMACOL., 58, 19-25, 1979.
74. Subramaniam K., Subramaniam B., Steinbrook R. A., Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review, ANESTH. ANALG., 99, 482-495, table of contents, 2004.
75. Sugimoto M., Uchida I., Mashimo T., Local anaesthetics have different mechanisms and sites of action at the recombinant N-methyl-D-aspartate (NMDA) receptors, BR. J. PHARMACOL., 138, 876-882, 2003.
76. Svensson C. I., Yaksh T. L., The spinal phospholipase-cyclooxygenase- prostanoid cascade in nociceptive processing, ANNU. REV. PHARMACOL. TOXICOL., 42, 553-583, 2002.
77. Thomas J., Kronenberg R., Cox M. C., et al., Intravenous lidocaine relieves severe pain: results of an inpatient hospice chart review, J. PALLIAT. MED., 7, 660-667, 2004.
78. Turan A., Karamanlioglu B., Memis D., et al., Analgesic effects of gabapentin after spinal surgery, ANESTHESIOLOGY, 100, 935-938, 2004.
79. Turan A., Karamanlioglu B., Memis D., et al., The analgesic effects of gabapentin after total abdominal hysterectomy, ANESTH. ANALG., 98, 1370-1373, table of contents, 2004.
80. Turan A., White P. F., Karamanlioglu B., et al., Gabapentin: an alternative to the cyclooxygenase-2 inhibitors for perioperative pain management, ANESTH. ANALG., 102, 175-181, 2006.
81. Unlugenc H., Gunduz M., Guler T., et al., The effect of pre-anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient-controlled morphine, EUR. J. ANAESTHESIOL., 22, 386-391, 2005.
82. Viscusi E. R., Goldstein S., Witkowski T., et al., Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study, SURG. ENDOSC., 20, 64-70, 2006.
83. Wilcox G. L., Excitatory neurotransmitters and pain. In: Bond M. R., Charlton J. E., Woolf C. J., eds. Pain Research and Clinical Management, Vol. 4, VIth World Congress on Pain. Amsterdam: Elsevier, 97-117, 1991.
84. Woolf C. J., Thompson S. W. N., The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states, PAIN, 44, 293-299, 1991.
85. Yaksh T. L., Dirig D. M., Conway C. M., et al. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1, J. NEUROSCI., 21, 5847-5853, 2001.
86. Yuan C. S., Doshan H., Charney M. R., et al., Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans, J. CLIN. PHARMACOL., 45, 538-546, 2005.
87. Yuan C. S., Foss J. F., O'Connor M., et al., Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial, JAMA, 283, 367-372, 2000.
88. Yuan C. S., Foss J. F., O'Connor M., et al., Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial, CLIN. PHARMACOL. THER., 59, 469-475, 1996.
89. Yuan C. S., Foss J. F., Osinski J., et al., The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time, CLIN. PHARMACOL. THER., 61, 467-475, 1997.
90. Zimmerman D. M., Gidda J. S., Cantrell B. E., et al., Discovery of a potent, peripherally selective trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonist for the treatment of gastrointestinal motility disorders, J. MED. CHEM., 37, 2262-2265, 1994.